Company News

May 5, 2022


Please join us at Immunology 2022 meeting May 6th to 10th in Portland, OR at the Oregon Convention Center. The largest annual meeting event worldwide, the AAI annual meeting is where leading researchers come to learn the latest in their field. Visit iXCells Biotechnologies at booth 731 in the Exhibit Hall to see our latest products, services, and advancements! 

Mar 23, 2022


We are excited to annoce that we will be attending the Society of Toxicology (SOT) 61st Annual Meeting and ToxExpo from March 27th to March 31st in San Diego, California. Visit us at booth 1921 in the Exhibit Hall to see our latest products, service and advancements!

Feb 10, 2022


A recent publication highlighting our hiPSC-derived motor neurons (iPSC-MN) can mature in vivo after transplanted into rat spinal cord. Significant motor axonal extension after transplantation in the animal models demonstrates that motor neuron replacement therapy could be a promising therapeutic strategy for amyotrophic lateral sclerosis (ALS).

Feb 7, 2022


In this interview with Nianwei Lin, Co-Founder and President of iXCells Biotechnologies, we discuss the company’s product pipeline, innovative drug discovery solutions, CRO services, and its future goals.

Dec 21, 2021


iXCells Biotechnologies, a provider of induced pluripotent stem cells (iPSCs), differentiation services, primary cells, media and reagents for drug discovery and development, today announced key growth initiatives.



Search Our Products